Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156260 · ClinicalTrials.gov registry record
Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Terminated
- Registry status
- 88
- Enrollment target
NCT00156260 is a clinical trial that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 88 participants.
The verdict
NCT00156260 was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.
- TERMINATED
- Registry status
- 88 participants
- Enrollment target
Study Summary
The primary purpose of this research is to analyze the cells present in the fluid obtained via ductal lavage from the nipple of a woman with a known diagnosis of breast cancer. A portion of the lavage fluid may be used in future breast cancer biomarkers. Remaining lavage fluid will be used to analyze its biochemical composition, for investigational purposes only.
Interventions
- PROCEDURE Ductal lavage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00156260
The ClinicalTrials.gov registry entry for NCT00156260 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ductal lavage is the first listed.
NCT00156260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00156260 about?
NCT00156260 is a clinical study titled "Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage". The primary purpose of this research is to analyze the cells present in the fluid obtained via ductal lavage from the nipple of a woman with a known diagnosis of breast cancer. A portion of the lavage fluid may be used in future breast cancer biomarkers. Remaining lavage fluid will be used to analyz...
What is the current status of trial NCT00156260?
This trial is currently terminated. The enrollment target is 88 participants. The study started on 2003-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00156260?
The interventions under investigation include: Ductal lavage (PROCEDURE).
Who is sponsoring clinical trial NCT00156260?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.